Shimuye Kalayu Yirga has done his PhD student in School of Life Sciences, Fujian Agriculture and Forestry University in China. Since 2013, he has been working as a Lecturer at Woldia University in Ethiopia.
His PhD research focuses on molecular immunology, production of monoclonal antibody and antibody cancer therapy.
Recently he found an IgG2a, IgG2b and IgG3 monoclonal antibody against kidney toxin and characterized using different immunoassay.
He has done his Bachelor’s degree from Haramaya University, Master’s degree from Bahir Dar University in Ethiopia.